Joan Gu

750 total citations
15 papers, 412 citations indexed

About

Joan Gu is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joan Gu has authored 15 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joan Gu's work include Attention Deficit Hyperactivity Disorder (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Treatment of Major Depression (3 papers). Joan Gu is often cited by papers focused on Attention Deficit Hyperactivity Disorder (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Treatment of Major Depression (3 papers). Joan Gu collaborates with scholars based in United States, Canada and Germany. Joan Gu's co-authors include Edward M. Sellers, Patrick E. Ciccone, Reinhard Schuller, Dolly A. Parasrampuria, Qian Gao, Michaël Otto, Cuong Vuong, Yumei Wen, Steven A. Silber and Kerri A. Schoedel and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Joan Gu

14 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Gu United States 9 101 94 74 73 73 15 412
Takanori Funaki Japan 11 25 0.2× 116 1.2× 39 0.5× 23 0.3× 145 2.0× 51 456
Kenichiro Kaneko Japan 11 62 0.6× 87 0.9× 183 2.5× 51 0.7× 109 1.5× 24 452
Loïc Le Guennec France 13 36 0.4× 30 0.3× 97 1.3× 76 1.0× 112 1.5× 42 625
Jeremy Woodward United Kingdom 14 48 0.5× 40 0.4× 252 3.4× 33 0.5× 104 1.4× 46 704
Václav Čapek Czechia 11 30 0.3× 24 0.3× 32 0.4× 49 0.7× 79 1.1× 44 325
Yu-Chiao Wang Taiwan 12 14 0.1× 58 0.6× 77 1.0× 24 0.3× 71 1.0× 36 366
G.E. Yousef United Kingdom 9 252 2.5× 148 1.6× 38 0.5× 95 1.3× 120 1.6× 10 524
R Deutsch United States 7 13 0.1× 32 0.3× 66 0.9× 48 0.7× 161 2.2× 9 537
Mei‐Ling Sharon Tai Malaysia 13 29 0.3× 106 1.1× 114 1.5× 11 0.2× 36 0.5× 27 424
Adolfo Martínez Spain 8 19 0.2× 11 0.1× 55 0.7× 16 0.2× 46 0.6× 23 276

Countries citing papers authored by Joan Gu

Since Specialization
Citations

This map shows the geographic impact of Joan Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Gu more than expected).

Fields of papers citing papers by Joan Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Gu. The network helps show where Joan Gu may publish in the future.

Co-authorship network of co-authors of Joan Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Gu. A scholar is included among the top collaborators of Joan Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Gu. Joan Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Blumberg, Emily A., Oliver Witzke, Michael G. Ison, et al.. (2024). Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study. The Journal of Heart and Lung Transplantation. 44(6). 986–994. 1 indexed citations
2.
Chou, Sunwen, Drew J. Winston, Robin K. Avery, et al.. (2024). Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection. The Journal of Infectious Diseases. 231(3). e470–e477. 5 indexed citations
3.
Ozelo, Margareth C., Cédric Hermans, Manuel Carção, et al.. (2024). The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study. Therapeutic Advances in Hematology. 15. 1564136384–1564136384. 5 indexed citations
4.
5.
Mayo, Marlyn J., Paul J. Pockros, David Jones, et al.. (2019). A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. Hepatology Communications. 3(3). 365–381. 68 indexed citations
6.
7.
Huß, Michael, Bryan Dirks, Joan Gu, et al.. (2018). Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD. European Child & Adolescent Psychiatry. 27(10). 1283–1294. 17 indexed citations
8.
Richards, Cynthia, Dan V. Iosifescu, Rajnish Mago, et al.. (2018). A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. Journal of Clinical Psychopharmacology. 38(4). 336–343.
9.
Fordyce, Christopher B., Hussein R. Al‐Khalidi, James G. Jollis, et al.. (2017). Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment–Elevation Myocardial Infarction Networks. Circulation Cardiovascular Interventions. 10(1). 37 indexed citations
10.
McBurnett, Keith, Andrew J. Cutler, Amaia Hervás, et al.. (2016). Separating efficacy and sedative effects of guanfacine extended release in children and adolescents with ADHD from four randomized, controlled, phase 3 clinical trials. European Psychiatry. 33(S1). S76–S77. 1 indexed citations
11.
Al‐Khatib, Sana M., James P. Daubert, Kevin J. Anstrom, et al.. (2014). Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial. Journal of Cardiovascular Electrophysiology. 26(2). 151–157. 66 indexed citations
12.
13.
Parasrampuria, Dolly A., et al.. (2007). Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic‐Controlled Extended‐Release Methylphenidate Formulation in Humans. The Journal of Clinical Pharmacology. 47(12). 1476–1488. 42 indexed citations
14.
Parasrampuria, Dolly A., Kerri A. Schoedel, Reinhard Schuller, et al.. (2007). Do Formulation Differences Alter Abuse Liability of Methylphenidate?. Journal of Clinical Psychopharmacology. 27(5). 459–467. 60 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takanori Funaki Breakdown of academic impact, for papers by Kenichiro Kaneko Breakdown of academic impact, for papers by Loïc Le Guennec Breakdown of academic impact, for papers by Jeremy Woodward Breakdown of academic impact, for papers by Václav Čapek Breakdown of academic impact, for papers by Yu-Chiao Wang Breakdown of academic impact, for papers by G.E. Yousef Breakdown of academic impact, for papers by R Deutsch Breakdown of academic impact, for papers by Mei‐Ling Sharon Tai Breakdown of academic impact, for papers by Adolfo Martínez
Rankless by CCL
2026